Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein

Cancer Biology and Therapy

Volumn 3, Issue 4, 2004, Pages 377-381

  Shi, Yongquan ^a   Zhang, Yumei ^a   Zhao, Yanqiu ^a   Hong, Liu ^a   Liu, Na ^a   Jin, Xiaohang ^a   Pan, Yanglin ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance, multiple; Neoplasm, stomach; P glycoprotein; ZNRD1

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; MESSENGER RNA; PROTEIN; PROTEIN ZNRD1; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE; ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; ZNRD1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SENSITIVITY; DRUG SENSITIZATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; NORTHERN BLOTTING; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; STOMACH CANCER; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; BIOSYNTHESIS; CELL CULTURE; GENETICS; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE; HUMANS; P-GLYCOPROTEIN; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 4344572739     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.4.724     Document Type: Article

References (23)

1. Fan D, Liu X. New progresses in researches on multidrug resistance in gastric cancer. Zhong Hua Xiao Xua Tsa Chih 2000; 20:77-8.
2. Ross DD. Novel mechanisms of drug resistance in leukemia. Leukemia 2000; 14:467-73.
3. Litman T, Druley TE, Stein WD, Bates SE. From MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci 2001; 58:931-59.
4. Fan KC, Fan DM, Cheng LF, Li CH. Expression of multidrug resistance related markers in gastric cancer. Anticancer Res 2000; 20:4809-14.
5. Gurel S, Yerci O, Filiz G, Dolar E, Yilmazlar T, Nak SG, et al. High expression of multidrug resistance-1 (MDR-1) and its relationship with multiple prognostic factors in gastric carcinomas in patients in Turkey. J Int Med Res 1999; 27:79-84.
6. Yeh KH, Chen CL, Shun CT, Lin JT, Lee WJ, Lee PH, et al. Relatively low expression of multidrug resistance-1 (MDR-1) and its possible clinical implication in gastric cancers. J Clin Gastroenterol 1998; 26:274-8.
7. Alexander D, Yamamoto T, Kato S, Kasai S. Histopathological assessment of multidrug resistance in gastric cancer: Expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein. Surg Today 1999; 29:401-6.
8. Takebayashi Y, Akiyama S, Natsugoe S, Hokita S, Niwa K, Kitazono M, et al. The expression of multidrug resistance protein in human gastrointestinal tract carcinomas. Cancer 1998; 82:661-6.
9. Zhao Y, You H, Liu F, An H, Shi Y, Yu Q, et al. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells. Cancer Lett 2002; 185:211-8.
10. Zhang YM, Zhao YQ, Pan YL, Shi YQ, Jin XH, Yi H, et al. Effect of ZNRD1 gene antisense RNA on drug resistantgastric cancer cells. World J Gastroenterol 2003; 9:894-8.
11. Cai XJ, Fan DM, Zhang XY. Establishment and biological characteristics of multidrug-resistant gastric cancer cell lines. J Chin Clin Cancer 1994; 9:56-63.
12. Hong L, Zhang Y, Han S, Wang J, Pan Y, Liu N, et al. Preparation and characterization of a novel monoclonal antibody specific to human ZNRD1 protein. Hybridoma Hybridomics 2004; accepted.
13. Shi Y, Han Y, Wang X, Zhao Y, Ning X, Xiao B, et al. MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells. Gastric Cancer 2002; 5:154-9.
14. Shi Y, Zhai H, Wang X, Wu H, Ning X, Han Y, et al. Multidrug-resistance- associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor. Cell Mol Life Sci 2002; 59:1577-83.
15. Fan W, Wang Z, Kyzysztof F, Prange C, Lennon G. A new zinc ribbon gene (ZNRD1) is cloned from the human MHC class 1 region. Genomics 2000; 63:139-41.
16. Deng L, Tatebe S, Lin-Lee YC, Ishikawa T, Kuo MT. MDR and MRP gene families as cellular determinant factors for resistance to clinical anticancer agents. Cancer Treat Res 2002; 112:49-66.
17. Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto LG. Transcriptional regulators of the human multidrug resistance 1 gene: Recent views. Biochem Pharmacol 2002; 64:943-8.
18. Potocnik U, Glavac MR, Golouh R, Glavac D. The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer. Pflugers Arch 2001; 442:R182-3.
19. Hu Z, Jin S, Scotto KW. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J Biol Chem 2000; 275:2979-85.
20. Hirose M. The role of Wilms' tumor genes. J Med Invest 1999; 46:130-40.
21. Carrington D, Algar E. Overexpression of murine WT1 +/+ and -/- isoforms has no effect on chemoresistance but delays differentiation in the K562 leukemia cell line. Leuk Res 2000; 24:927-36.
22. McCoy C, McGee SB, Cornwell MM. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ 1999; 10:377-86.
23. Bartsevich VV, Juliano RL. Regulation of the MDR1 gene by transcriptional repressors selected using peptide combinatorial libraries. Mol Pharmacol 2000; 58:1-10.